Home
Active ingredients at their site of action
Personalized implants that release drugs exactly where they are supposed to act
Round window niche implant (RNI) for the treatment of hearing loss
To date, no medications are approved for the treatment of the various forms of hearing loss. One reason for this is that drugs have to be applied locally to the inner ear to have a beneficial effect. But until today, there is no approved device bringing the drug into the inner ear.
Bacta Implants technology enables the production of implants, fitting precisely and safe to your individual round window niche, which connects your middle and inner ear and allows inner ear therapy with minimal invasion.Our first product will be the Round Window Niche Implant (RNI), which delivers the drug dexamethasone, approved for decades, into the inner ear to treat sudden sensorineural hearing loss (ISSHL) – colloquially known as hearing loss.
Further information
You want to treat sudden idiopathic sensorineural hearing loss, but all conventional methods failed?
You suffer from idiopathic sudden sensorineural hearing loss?
You aim to administer an active substance into a living being, but the systemic application is not effective enough?
Bacta Implants wurde für eine Förderung durch das Institut für Biomedizinische Translation (IBT) Niedersachsen ausgewählt!
Fernsehbeitrag beim NDR
Kooperation mit Desktop Health
Bacta Implants als bester Pitch beim SMINT@Hannover Demo Day 2023 ausgezeichnet
Poster Preise bei der AMMM 2023
Posterpreis bei der ISIET 2023
We are founding a start-up company from the Hannover Medical School and open for investors.